INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
7.67
+1.15 (17.55%)
Jan 22, 2025, 4:00 PM EST - Market closed
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $170.06 million as of January 22, 2025. Its market cap has decreased by -21.95% in one year.
Market Cap
170.06M
Enterprise Value
138.54M
1-Year Change
-21.95%
Ranking
Category
Stock Price
$7.67
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has increased from $77.82M to $170.06M, an increase of 118.52%. That is a compound annual growth rate of 14.00%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 653.46B |
| UnitedHealth Group | 469.12B |
| Johnson & Johnson | 353.99B |
| Novo Nordisk | 352.70B |
| AbbVie | 303.17B |
| Merck & Co. | 247.70B |
| Thermo Fisher Scientific | 214.07B |
| Intuitive Surgical | 211.09B |